An underground market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting substances of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.
Service Reaction and Content Elimination
Based on TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.
After moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Details and Pricing
Inside these communities, posts display dark colored packages with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious medical dangers”.
